Hong Kong Stock Market Surges | Rongchang Biology (09995.HK) Rises Over 17% with Core Product Taetacyl Out for Overseas Licensing. RC148 Becomes Popular Area for Business Collaboration.

According to the Securities Times APP, Rongchang Biotechnology (09995.HK) has surged more than 17%, as of the time of publication, up 17.47% to 69.25 Hong Kong dollars, with a turnover of 1.489 billion Hong Kong dollars.